EGFR Antibody
REGN-1400 is a fully human monoclonal antibody inhibitor targeting ErbB3. By inhibiting ErbB3, REGN-1400 blocks associated signaling pathways to reduce tumor cell proliferation. It shows potential for research in solid tumors such as non-small cell lung cancer (NSCLC), colorectal cancer (CRC), and squamous cell carcinoma of the head and neck (SCCHN) .
Product Specifications
Target
EGFR
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Cardiovascular Research, Cell Biology, Signal Transduction
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15160489 1 Vial
Lentiviral human PSMA3 shRNA (UAS) - Lentiviral human PSMA3 shRNA (UAS, RFP) plasmid
Sign In for Pricing
View Details